@article{article, title  = {{Real-world evidence from a single U.K. cancer center for atezolizumab in second-line setting in advanced urothelial cancer: Moving beyond clinical trials.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2022}},

 month = {{2}},

 author = {{Hussain SA and Qureshi M and Tahir B and Rehan A and Catto JWF}},

 doi = {{10.1200/jco.2022.40.6_suppl.461}},

 volume = {{40}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{6_suppl}},

 pages = {{461-461}},

 note = {{Accessed on 2024/12/22}}}